...
机译:在基因型1或4个HCV感染患者中,具有或不含Dasbuvir(DSV)方案的疗效和ritonavir(prv / r)的疗效和安全性的疗效和安全性。 希腊多中心真实队列队列研究
Univ Athens Dept Gastroenterol Laiko Gen Hosp Athens Greece;
Gen Hosp Western Attica Agia Varvara Athens Greece;
Univ Athens Dept Internal Med Hepatogastroenterol Unit Gen &
Oncol Hosp Kifisia Agioi Anargyroi;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Univ Athens Dept Gastroenterol Laiko Gen Hosp Athens Greece;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Univ Thessaly Sch Med Dept Med Larisa Greece;
Aristotle Univ Thessaloniki Hippokratio Hosp Med Dept 4 Thessaloniki Greece;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Gen Hosp Rhodes Dept Internal Med 1 Rhodes Greece;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Evangelismos Gen Hosp Dept Internal Med 4 Athens Greece;
Aristotle Univ Thessaloniki Hippokratio Hosp Med Dept 4 Thessaloniki Greece;
Euroclin SA Liver Unit Athens Greece;
Univ Athens Dept Gastroenterol Laiko Gen Hosp Athens Greece;
Gen Hosp Western Attica Agia Varvara Athens Greece;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Univ Athens Dept Internal Med Hepatogastroenterol Unit Gen &
Oncol Hosp Kifisia Agioi Anargyroi;
Univ Athens Dept Gastroenterol Laiko Gen Hosp Athens Greece;
Univ Athens Hippokratio Gen Hosp Athens Dept Internal Med 2 Athens Greece;
Aristotle Univ Thessaloniki Hippokratio Hosp Med Dept 4 Thessaloniki Greece;
Gen Hosp Rhodes Dept Internal Med 1 Rhodes Greece;
Evangelismos Gen Hosp Dept Internal Med 4 Athens Greece;
Aristotle Univ Thessaloniki Hippokratio Hosp Med Dept 4 Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokratio Hosp Med Dept 4 Thessaloniki Greece;
Univ Thessaly Sch Med Dept Med Larisa Greece;
Univ Athens Dept Gastroenterol Laiko Gen Hosp Athens Greece;
机译:在基因型1或4个HCV感染患者中,具有或不含Dasbuvir(DSV)方案的疗效和ritonavir(prv / r)的疗效和安全性的疗效和安全性。 希腊多中心真实队列队列研究
机译:HCV基因型1-或4单型感染患者的Combatasvir / ParitaTavir / Ritonavir +/- dasabuvir的安全性和有效性来自法国ANRS CO22 Hepather Cohort
机译:在美国退伍军人中有或没有利尿运因的开放标签,多中心研究,或没有基因型1慢性丙型肝炎感染:Topaz-VA的疗效和安全结果
机译:Ombitasvir / Paritaprevir / Ritonavir加上Dasabuvir含或不含利巴韦林的HCV感染患者同时服用降酸药的安全性和有效性
机译:直接作用抗病毒药虫/ paritabrevir / ritonavir + dasabuvir在丙啶病毒(hcv)基因虫中(hcv)基因型1-感染的治疗 - 幼稚或治疗 - 经验丰富的患者或没有肝硬化的患者:立陶宛和拉脱维亚的现实生活经验